Metronidazole Unifarma

Metronidazole, the active ingredient in Metronidazole Unifarma, is a nitroimidazole antibiotic presented as an injectable solution for intravenous use. It treats a range of anaerobic bacterial and protozoal infections in adult and pediatric patients as prescribed by a healthcare professional.

GNH USA supplies Metronidazole Unifarma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metronidazole is a nitroimidazole antibiotic used to manage infections caused by anaerobic bacteria and certain protozoa. - Anaerobic bacterial infections: eradicates susceptible anaerobes and reduces infection severity. - Bacterial vaginosis: restores normal vaginal flora by targeting Gardnerella and related organisms. - Trichomoniasis: eliminates Trichomonas vaginalis, relieving symptoms and preventing transmission. - Amoebiasis: clears intestinal Entamoeba histolytica and hepatic abscesses. - Intra‑abdominal infections: controls mixed aerobic‑anaerobic infections following surgery or perforation. - Pelvic inflammatory disease: treats polymicrobial pelvic infections involving anaerobes.

Metronidazole may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Metallic taste: transient metallic sensation in the mouth. - Headache: mild to moderate headache. - Diarrhea: loose stools during therapy. - Abdominal pain: cramping or discomfort. - Dizziness: occasional light‑headedness.

Serious or Rare Side Effects: - Seizures: rare neurologic events. - Peripheral neuropathy: tingling or numbness in extremities. - Severe allergic reactions: rash, itching, swelling, or anaphylaxis. - Stevens‑Johnson syndrome: severe skin blistering. - Liver toxicity: elevated enzymes or hepatitis. - Pancytopenia: reduction in blood cell counts.

Before initiating therapy, clinicians should assess patient‑specific factors and monitor for potential complications. - Renal function: adjust dosing in severe impairment. - Hepatic function: monitor liver enzymes during prolonged use. - Alcohol consumption: avoid to prevent disulfiram‑like reactions. - Central nervous system disorders: use cautiously in patients with seizures or neuropathy. - Hypersensitivity: discontinue if allergic signs appear. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Metronidazole can alter the activity of several co‑administered drugs; careful review is required.

Major Interactions (Avoid): - Alcohol: may cause severe flushing, tachycardia, and hypotension. - Warfarin: potentiates anticoagulant effect, increasing bleeding risk. - Lithium: can raise serum lithium levels, leading to toxicity.

Moderate Interactions (Monitor Closely): - Rifampin: induces metabolism, reducing metronidazole exposure. - Phenytoin: decreases metronidazole concentrations. - Carbamazepine: may lower drug levels. - Oral contraceptives: may reduce hormonal efficacy, consider backup contraception.